HVTN Translational HIV Vaccine Early Stage Investigator (ESI) Conference

October 9-10, 2023


Registration Closed.



UC Davis Conference Center in Davis, CA
Link to Campus Map

ESI Conference Overview

The HIV Vaccine Trials Network is proud to announce that it will host the 7th Translational HIV Vaccine Early Stage Investigator Conference, October 9-10, 2023, prior to the NHP AIDS Symposium. 

This conference is intended for ESIs who focus on translational HIV research in non-human primates (NHPs), or clinical HIV and TB research. Investigators participating in the conference will gain a sense of their ability to contribute widely to the field and obtain support in reaching career milestones. Past attendees have stated that the Conference has increased their skills and knowledge for career development and provided them with a venue to form new collaborations.

Target Audience

ESIs who focus on preclinical or clinical HIV vaccine research and are within ten (10) years of completing their terminal research degree (PhD, MD, DVM), medical residency, or equivalent.

Travel Award

The HVTN will offer a limited number of travel awards to attend this conference. The deadline to submit an application is July 7th, 2023.

Application Closed

COVID-19-related Policies (subject to change)

Daily testing and reporting will be required. Tests will be supplied and available for pickup starting the evening of October 8th. More information about testing and reporting procedures will be sent via email to all attendees. Masks are not required but strongly encouraged. Masks will be available at the registration desk throughout the conference.


Click here to view the 2023 conference program.


NHP AIDS Symposium

The HVTN Translational ESI Conference will take place prior to the NHP AIDS Symposium, which is being held October 11-13, 2023, at the University of California Davis Activities and Recreation Center, in Davis, CA. Participation in the NHP Symposium will provide attendees further opportunities to expand their knowledge of HIV vaccine science and to continue to develop professional networks.

Funding for this conference was made possible in part by 2R13OD024033 from the Office of the Director, National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the National Institutes of Health (NIH); nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.






Conference Contacts

For questions about the conference, please contact Sydney Callens at scallens@fredhutch.org